Upregulation of IL-4/IL-4R signaling in TAMs results in their increased secretion of insulin-like growth factor (IGF-1), which, upon binding to IGF-1 receptor (IGF-1R) on tumor cells, upregulates the PI3K pathway, promoting tumor growth and malignancy [31]. This evidence concerns the gene IL4 and neoplasm.